Lopez, I used a terminal growth rate for Ryoncils FDA approval earnings of 12% and a discount rate of 17%. Obviously I am only valuing the FDA approved component of MSB. There is plenty of Blue Sky in MSB's pipeline but we have to see the management team grow revenues with what has been approved to see much higher share prices in my opinion. Next weeks update may help in this regard.
MSB Price at posting:
$2.66 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)